CSIMarket
 


Tracon Pharmaceuticals Inc   (TCON)
Other Ticker:  
 

Cumulative Tracon Pharmaceuticals Inc 's Quick Ratio for Trailing Twelve Months Period

TCON's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

TCON Quick Ratio for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities Growth -15.82 % 2451.65 % 21.53 % 285.36 % -65.38 %
Y / Y Cash & cash equivalent Growth -54.43 % -87.22 % -60.28 % -27.58 % -33.4 %
Quick Ratio for Trailing Twelve Months Period 0.81 1.03 3.54 4.28 10.52
Total Ranking # 2077 # 2003 # 1761 # 1929 # 1721
Seq. Current Liabilities Growth -96.01 % 1371.36 % -83.66 % 777.94 % 20.92 %
Seq. Cash & cash equivalent Growth 347.44 % -73.75 % -62.08 % 2.32 % 25.46 %


Quick Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis Despite year on year decrease in Tracon Pharmaceuticals Inc 's average Current Liabilities to $1 millions, Quick Ratio for Trailing Twelve Months Period to 0.81 below company average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Pharmaceuticals industry 51 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Tracon Pharmaceuticals Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about TCON
Quick Ratio TCON in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 52
Sector # 231
S&P 500 # 319


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
4.02 2.42 0.45
(Sep 30 2017)   (Sep 30 2023)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Biotechnology & Pharmaceuticals Industry Quick Ratio for Trailing Twelve Months Period
Cellectis S a   2.17 
Qiagen N v   2.13 
Logicbio Therapeutics Inc   2.04 
Innate Pharma Sa  2.04 
Biondvax Pharmaceuticals Ltd   2.02 
Fate Therapeutics Inc   1.97 
Bluebird Bio Inc   1.91 
Seagen Inc   1.85 
Moderna Inc   1.78 
Evaxion Biotech A  1.78 
Nanostring Technologies Inc   1.76 
Titan Pharmaceuticals Inc   1.74 
Neurocrine Biosciences Inc   1.68 
Cidara Therapeutics Inc   1.62 
Repligen Corp  1.59 
Adma Biologics Inc   1.58 
Lexeo Therapeutics Inc   1.54 
Freeline Therapeutics Holdings Plc  1.53 
Cargo Therapeutics Inc   1.47 
Bio techne Corp  1.44 
Biocardia Inc  1.42 
Amgen Inc   1.40 
Pluri Inc   1.39 
Meiragtx Holdings Plc  1.33 
Armata Pharmaceuticals Inc   1.32 
Aerie Pharmaceuticals Inc   1.29 
Applied Genetic Technologies Corporation  1.29 
Ladrx Corporation  1.25 
Eiger Biopharmaceuticals Inc   1.23 
Champions Oncology Inc   1.19 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com